Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Private equity-backed Medline files for IPO
The company, founded in 1966, has been providing supplies to cardiac surgery suites and cath labs for decades.
Key takeaways for interventional cardiology from TCT 2025
B. Hadley Wilson, MD, talked to Cardiovascular Business about several standout late-breaking clinical trials presented at TCT 2025. Topics of those trials included drug-coated balloons, TAVR valve durability, pulmonary embolism treatments and much more.
More good news for renal denervation: FDA-approved systems linked to positive long-term data
New data on the RDN systems from Recor Medical and Medtronic confirmed that this relatively new technology brings long-term relief to patients with uncontrolled hypertension.
Nearly 600K bottles of blood pressure drug recalled due to carcinogen risk
The FDA has detailed three voluntary recalls for prazosin hydrochloride, a medication used to treat hypertension, due to safety concerns.
Patient sues Abbott after early heart valve replacement
The patient's Trifecta GT heart valve had to be replaced after just six years, an experience he says resulted in "permanent injuries." Abbott pulled the devices off the U.S. market in 2023 due to a known risk of structural valve deterioration.

Tafamidis boosts survival for patients with transthyretin amyloid cardiomyopathy

This latest analysis tracked more than 300 patients for a median follow-up period of nearly five years.

3 ways Vanderbilt's radiology department is laying the groundwork to address health disparities

"Regardless of design, developing a critical mass of institutions with this type of infrastructure will be needed for the field of radiology to improve health equity," experts wrote in JACR.

DOACs underprescribed among high-risk AFib patients

The study found that frail patients with AFib are less likely to be treated with DOAC therapy.

Edwards gains FDA approval for new Sapien 3 solution for TPV replacement

The system was designed to treat both pediatric and adult patients.

Metoprolol demonstrates value as a treatment for obstructive hypertrophic cardiomyopathy

The small study, published in the Journal of the American College of Cardiology, compared patient outcomes associated with metoprolol and a placebo.

AI improves detection of severe CAD in stress echocardiograms

Advanced algorithms can lead to significant improvements in agreement among specialists, researchers found.

CDC now recommends Moderna, Pfizer/BioNTech COVID-19 vaccines over Johnson & Johnson’s due to risk of fatal blood clots

Johnson & Johnson’s vaccine has been associated with an elevated risk of thrombosis with thrombocytopenia syndrome.

Cardiologist interviewed by Joe Rogan claims U.S. withheld early COVID-19 treatments to promote fear, push support for vaccines

Peter A. McCullough, MD, has been no stranger to controversy during the ongoing pandemic.

Clinical

Private equity-backed Medline files for IPO

Key takeaways for interventional cardiology from TCT 2025

More good news for renal denervation: FDA-approved systems linked to positive long-term data

Nearly 600K bottles of blood pressure drug recalled due to carcinogen risk

Patient sues Abbott after early heart valve replacement